Nephrogenic Systemic Fibrosis Risk and Liver Disease

Objective. Evaluate the incidence of nephrogenic systemic fibrosis (NSF) in patients with liver disease in the peritransplant period. Materials and Methods. This IRB approved study retrospectively reviewed patients requiring transplantation for cirrhosis, hepatocellular carcinoma (HCC), or both from...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanna, Robert F., Finkelstone, Lee A., Chow, Daniel S., Miloushev, Vesselin Z., Escudero, Mark R., Lagana, Stephen M., Prince, Martin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981185/
https://www.ncbi.nlm.nih.gov/pubmed/24778878
http://dx.doi.org/10.1155/2014/679605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981185/
https://www.ncbi.nlm.nih.gov/pubmed/24778878
http://dx.doi.org/10.1155/2014/679605

Ejemplares similares